News
Evotec: Gute News zum Handelsstart
Der Wirkstoffhersteller Evotec meldet heute vorbörslich den Abschluss einer neuen Forschungs-Kooperation. Zusammen mit ABIVAX soll am französischen Standort im Bereich „Behandlung von schweren....
Here's Why Voyager Therapeutics Gained as Much as 24.9% Today
Shares of clinical-stage biopharma Voyager Therapeutics (NASDAQ: VYGR) popped nearly 25% today after the company announced positive results for a phase 1b trial investigating the potential of its....
Upcoming Data Releases Fueled Strong Gains in These 2 Marijuana Stocks Last Week
Though speculators' eyes may be on bitcoin and other cryptocurrencies at the moment, arguably no group of stock-based equities has been stronger over the trailing year than marijuana stocks. If we....
Could These 2 Biotech Stocks Really Double Your Money?
Investment-bank analysts have been slapping lofty price targets on small-cap biotech stocks recently. More than a few targets I've seen recently suggest you could easily double your money or....
What's Behind Mallinckrodt's 12.2% Tumble Today
Growing concern that generic alternatives to one of its best-selling drugs could threaten future sales and that an investigation into the marketing of opioid pain medication could create headwinds....
Quantum Genomics Receives FDA Clearance of IND Application for QGC001
Company to Launch NEW-HOPE, a targeted Phase II clinical trial in Hypertension in the U.S.
Paris & New York, September 5, 2017
Quantum Genomics (Euronext Growth − FR0011648971 − ALQGC;....
Quantum Genomics reçoit l'accord de la FDA pour le lancement de l'étude NEW-HOPE de phase II aux Etats-Unis dans l'hypertension artérielle
Paris, le 5 septembre 2017
Quantum Genomics (Euronext Growth − FR0011648971 − ALQGC), société biopharmaceutique dont la mission est de développer de nouvelles thérapies pour des besoins....
Here's Why Insmed Incorporated Is Skyrocketing
Investors in Insmed (NASDAQ: INSM) are having an incredible start to the short trading week. Shares of the rare disease focused biotech are up 110% as of 11:15 a.m. EDT, after the company....
3 Charts That Show Why Aurinia Pharmaceuticals Stock Could Go Higher
Aurinia Pharmaceuticals (NASDAQ: AUPH) stock is without question one of the best-performing biotech stocks so far in 2017. Shares of the red-hot biotech have tripled in price year to date. Aurinia....
5 of the Most Hated Biotech Stocks on the Market: Are They Buys?
One of the best ways to measure how much a stock is hated is by looking at the percentage of the stock's float that's sold short. Short-sellers think so poorly of a stock that they're willing to....
Why Investors Bid Immunogen Inc. Up Almost 12% Today
News that Irish biotech Jazz Pharmaceuticals (NASDAQ: JAZZ) had signed on to collaborate with Immunogen Inc. (NASDAQ: IMGN) in the development of drugs in the smaller, Massachusetts-based....
Here's Why the Market Is Eviscerating Otonomy Inc. Stock Today
Otonomy Inc. (NASDAQ: OTIC) stock cratered Wednesday morning after the biotech and biopharmaceuticals company announced truly dismal results from a pivotal Phase 3 trial for its steroid candidate....
The Only Marijuana Stock to Rise by More Than 10% Last Week
The marijuana industry is growing like a weed, and it's been putting smiles on the faces of marijuana stock investors. Of the one dozen largest marijuana stocks by market cap, a vast majority are....
Why Movado Group, Catalent, and ImmunoGen Jumped Today
The stock market slowly climbed over the course of Tuesday's session as geopolitical events and the continuing aftermath of Hurricane Harvey dominated headlines. Investors were initially rattled....
Why Acorda Therapeutics Is Losing One-Quarter of Its Value Today
After reporting that it has received a refuse-to-file letter from the FDA regarding its Parkinson's disease drug, Inbrija, shares in Acorda Therapeutics (NASDAQ: ACOR) are crashing 25% at 12:30....
Why ImmunoGen, Inc. Jumped Higher Today
Shares of ImmunoGen (NASDAQ: IMGN) are up 17.5% at 12:50 p.m. EDT after the company announced an option deal with Jazz Pharmaceuticals (NASDAQ: JAZZ) for three antibody-drug conjugate (ADC) drugs....
Is Inovio Pharmaceuticals Stock Poised for a Rebound?
2017 was shaping up to be a good year for Inovio Pharmaceuticals (NASDAQ: INO). The stock was up more than 15% halfway through the year. And then shareholders got the bad news.In July, Inovio....
Why Adamas Pharmaceuticals Inc Stock Skyrocketed Today
Shares of Adamas Pharmaceuticals (NASDAQ: ADMS) have skyrocketed today, up 42.3% as of 12:02 p.m. EDT, after the company announced yesterday evening that the Food and Drug Administration approved....
Here's Why Paratek Pharmaceuticals Soared as Much as 37% Today
Shares of clinical-stage biopharma Paratek Pharmaceuticals (NASDAQ: PRTK) soared 37% today after news leaked that the company is considering a sale.The stock has returned solid gains to investors....
2 Marijuana Stocks That Have Imploded Since August Began
In many ways, the legal marijuana industry could be described as the greatest thing since sliced bread for investors. Over the trailing one-year period, the average marijuana stock has increased....
3 Top Small-Cap Stocks to Buy in August
Small-cap stocks, or those with a market cap of between $300 million and $2 billion, often get a bad rap on Wall Street. Smaller companies are typically viewed as having untested business models,....
Why Shares of Control4 Corporation Are Spiking 10% on Its Addition to S&P SmallCap 600
Shares of Control4 Corporation (NASDAQ: CTRL), a leading provider of automation and premium control solutions for the connected smart home, are soaring 10% on Friday after it was announced the....
3 Reasons to Buy Aurinia Pharmaceuticals Stock Right Now
Aurinia Pharmaceuticals (NASDAQ: AUPH) has emerged as one of the hottest biotechs on the market this year. Its stock has tripled in value so far in 2017. And that's after a significant pullback of
Here's My Top Stock to Buy in August
Last year, Bank of America/Merrill Lynch released their analysis of an interesting study that examined the performance of growth stocks versus value stocks over the 90-year period from 1926 to 2016
This Technology Could Make You Rich -- and Change the World As We Know It
Revolutionary, game-changing, groundbreaking.These words are probably used too often in describing new innovations. The reality is that most new products and technologies don't live up to the hype